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Abstract
Delivery of effector proteins is a process widely used by bacterial pathogens to subvert host cell functions and cause
disease. Effector delivery is achieved by elaborate injection devices and can often be triggered by environmental stimuli.
However, effector export by the L. pneumophila Icm/Dot Type IVB secretion system cannot be detected until the bacterium
encounters a target host cell. We used chemical genetics, a perturbation strategy that utilizes small molecule inhibitors, to
determine the mechanisms critical for L. pneumophila Icm/Dot activity. From a collection of more than 2,500 annotated
molecules we identified specific inhibitors of effector translocation. We found that L. pneumophila effector translocation in
macrophages requires host cell factors known to be involved in phagocytosis such as phosphoinositide 3-kinases, actin and
tubulin. Moreover, we found that L. pneumophila phagocytosis and effector translocation also specifically require the
receptor protein tyrosine phosphate phosphatases CD45 and CD148. We further show that phagocytosis is required to
trigger effector delivery unless intimate contact between the bacteria and the host is artificially generated. In addition, real-
time analysis of effector translocation suggests that effector export is rate-limited by phagocytosis. We propose a model in
which L. pneumophila utilizes phagocytosis to initiate an intimate contact event required for the translocation of pre-
synthesized effector molecules. We discuss the need for host cell participation in the initial step of the infection and its
implications in the L. pneumophila lifestyle. Chemical genetic screening provides a novel approach to probe the host cell
functions and factors involved in host–pathogen interactions.
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Introduction
Legionella pneumophila is the causative agent of the acute
pneumonia known as Legionnaires’ disease [1,2]. Upon inhala-
tion, Legionella pneumophila infects and replicates in alveolar
macrophages, leading to inflammation and development of the
disease. Within host cells, L. pneumophila avoids phagosome-
lysosome fusion and manipulates host cell processes to create a
specialized phagosome that does not acidify and is suitable for
intracellular replication [3–5]. The Icm/Dot Type IVB secretion
system is required for avoiding phagosome-lysosome fusion and for
intracellular multiplication [6,7]. The Icm/Dot system mediates
translocation of multiple effector proteins that are responsible for
transforming the nascent Legionella phagosome into a replicative
compartment, called the Legionella-containing vacuole (LCV) [8].
After several hours, the LCV acquires characteristics of the
endoplasmic reticulum (ER) by intercepting small vesicles that
traffic between the golgi compartment and the ER [9]. Although
most effector proteins have uncharacterized functions, some have
been studied in detail and target multiple host cell processes
important for the intracellular survival of L. pneumophila [8,10]. For
example, LepA and LepB mediate non-lytic release of L.
pneumophila from protozoan hosts [11]. RalF, DrrA/SidM, LepB
and LidA interfere with regulators of ER to Golgi trafficking [12–
14]. While many other effectors can also interfere with vesicular
trafficking by unknown mechanisms [15–17], additional effectors
target the host innate immune response [18], phosphoinositide
metabolism [19] or ubiquitination [20]. The early requirement of
a functional Icm/Dot system suggests that effectors must be
rapidly translocated upon encounter of the host cell in order to
alter trafficking of the newly-formed phagosome and prevent its
fusion with the lysosome [21,22].
Little is known about the processes or signaling events that
trigger translocation of bacterial effectors to host cells. For many
bacterial pathogens that use a type III secretion system for effector
translocation, active release of the effector molecules in the culture
supernatants can be triggered in the absence of the host cell [23].
In contrast, for pathogens with type IV secretion system such as H.
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effectors has not been detected [24] and it is unclear whether or
not these pathogens can secrete as well as translocate effectors.
Even though L. pneumophila translocates a large repertoire of
effector proteins during the course of the infection, none of these
effectors are released until it encounters a target host cell [25].
This suggests that functional activation of the Icm/Dot system
requires sensing of an appropriate host cell by L. pneumophila.
Effector translocation might be triggered passively by stimuli
provided by the host cell. An alternate view is that effector
translocation requires the active participation of the host cell. We
sought to gain information about the bacterial and host cell factors
required for triggering effector translocation by conducting a
perturbation study of effector translocation using libraries of small
organic molecules with known targets, an approach called
chemical genetics [26,27]. In this approach, thousands of small
molecules with known protein targets are screened to identify
which proteins are involved in regulating a particular process. This
requires annotated libraries of known inhibitors as well as a high-
throughput screening assay for the investigated process. We used a
b-lactamase reporter system to monitor type IVB effector
translocation and adapted it to high-throughput screening.
Screening a collection of three commercial libraries consisting of
over 2500 bioactive molecules identified a relatively small number
of molecules that inhibit translocation. Many of these inhibitors
have eukaryotic targets, and some of these inhibit various stages of
actin cytoskeleton assembly required for phagocytosis. We show
that the triggering of effector translocation is dependent upon
phagocytosis and requires the active participation of the host cell.
Also, to gain more insight into the parameters that control effector
translocation we developed a kinetic translocation assay, which
enables detection of effector translocation in real time. We show
that host cell contact is a limiting factor for Icm/Dot-dependent
effector translocation and that artificially induced intimate contact
using the antibody-Fc receptor interaction can increase effector
translocation rates by more than 10-fold. Our results reconcile
previously conflicting results and provide evidence that phagocy-
tosis-mediated intimate contact of L. pneumophila with host cells is
critical for efficient effector translocation. We propose a model in
which L. pneumophila relies on the host cell-dependent phagocytosis
to create the intimate binding required to trigger effector
translocation.
Results
Measurement of L. pneumophila effector protein
translocation with the b-lactamase reporter system
The b-lactamase translocation reporter system [28] has been
widely used to monitor effector translocation by type III secretion
systems in various organisms [29–32]. We recently reported the
use of this system to detect Icm/Dot-dependent effector
translocation by L. pneumophila [16]. Host cells are infected with
bacteria expressing an effector fused to the C-terminal end of the
TEM-1 b-lactamase. The translocated b-lactamase activity in host
cells can be quantified using a spectrofluorimeter to measure the
concentrations of the cleaved (Emission at 460 nm) and intact
(Emission at 530 nm) b-lactamase substrate CCF4. We further
validated the reporter system by testing the translocation of the
previously reported Icm/Dot effector proteins RalF, LepA, LepB,
VipA, VipD, LidA as well as the non-translocated fatty acid
biosynthetic enzyme, enoyl-CoA reductase (FabI). As expected, b-
lactamase activity was detected in J774 cells infected with bacteria
(multiplicity of infection MOI=50) expressing the various TEM-
effector fusions but not in J774 cells infected with the bacteria
expressing TEM-FabI (Figure 1A and data not shown). In order to
determine the sensitivity and the linearity of the assay we infected
J774 cells with increasing numbers of bacteria expressing the
translocated TEM-LepA fusion protein. When J774 cells are
infected with less than 10 bacteria/cell the system seems to behave
linearly but above 25 bacteria/cell the system appears to saturate
as increases in MOI do not result in a corresponding increase in
the Em460/530 ratio (Figure 1B). As a compromise between
sensitivity and linearity, we selected MOI=20 as the standard
MOI in subsequent experiments. We also investigated the effect of
protein expression levels on translocation efficiency. L. pneumophila
expressing TEM-RalF, TEM-LepA or TEM-LegAU13 were
grown with varying amounts of IPTG to obtain a range of
increased protein expression levels (Figure 1C). In the absence of
IPTG no anti-TEM reactive protein could be detected by Western
Blot and little or no translocation could be detected. In contrast,
translocation of all effectors could be detected when expressed at
low levels using 10 mM IPTG. Increasing expression levels resulted
in increased translocation up to 50 mM IPTG, thus indicating that
effector production is a limiting factor. However, further increases
in protein expression levels did not result in increased effector
translocation. This plateau in translocation suggests that each
effector has a maximal rate of delivery to the host and that when
effector protein expression is not limiting, one or more additional
unknown factors limit effector translocation. In order to use the b-
lactamase translocation reporter assay for chemical genetic
screening we miniaturized it to the 384-well format and evaluated
its use for high throughput screening (HTS). The Z-factor is a
widespread measure of the quality or power of a HTS assay [33].
We found the TEM reporter to be a robust screening assay with a
Author Summary
Many bacterial pathogens subvert the cellular functions of
their host by translocating effector proteins into specific
cells. L. pneumophila primarily targets the alveolar macro-
phage in its human host or the unicellular protozoa in its
natural environment. The bacterium uses a Type IVB
secretion system called the Icm/Dot system to translocate
its effectors. In contrast to other injection devices, effector
secretion by the Icm/Dot system cannot be triggered
without the involvement of a target cell. We hypothesize
that activity of the Icm/Dot system responds to some
signaling or functional activation by the target cell. To
identify the host cell function required for activity of the
Icm/Dot system we used a small molecule-mediated
perturbation strategy called chemical genetics. We
screened more than 2,500 annotated small molecules to
identify inhibitors of L. pneumophila effector translocation
in the macrophage. Many of these molecules inhibited
known host cell factors involved in phagocytosis. We also
identified host cell factors specifically required for L.
pneumophila phagocytosis. We further show that phago-
cytosis of L. pneumophila by the macrophage is required to
trigger effector translocation by the Icm/Dot system. Our
data indicate that participation of the target cell is required
to generate an intimate contact that stimulates effector
translocation by the Icm/Dot system. The host cell
participation in the effector translocation process has
implications in the environmental lifestyle of L. pneumo-
phila. We propose that relying on an active host cell
process to stimulate translocation provides L. pneumophila
with a test for the fitness of the potential host cell. This
could prevent the unwanted delivery of L. pneumophila
effectors into non-productive hosts.
Host-Dependent Effector Translocation
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throughput screening of inhibitors of effector translocation.
Screening of known bioactive molecules and
identification of translocation inhibitors
In order to identify processes required for effector transloca-
tion, we took advantage of three libraries of small molecule
inhibitors with a wide variety of known prokaryotic and
eukaryotic targets. The Biomol ICCB Known Bioactives Library
is a collection of 480 diverse biologically active compounds with
defined biological activity and was developed in collaboration
with the Harvard Institute of Chemistry and Cell Biology. The
NINDS custom collection of 1,040 characterized bioactive
compounds was compiled by MicroSource Discovery Systems
for the National Institute of Neurological Disorders and Stroke
(NINDS). Three quarters of the compounds in the collection are
FDA-approved for use in humans. The Prestwick Chemical
LibraryH contains 1,120 off-patent compounds, 90% being
marketed drugs. The three libraries together represent 2,640
molecules (see Table S1 for complete list) and cover 46% of
FDA-approved active molecules (561 compounds). We screened
the three libraries for molecules that inhibited translocation of
the LepA effector from Legionella to macrophages (Figure 2). We
selected hits showing more than 50% inhibition. In spite of its
small size the Biomol library showed the highest hit rate (8.3%)
compared to the larger NINDS and Prestwick libraries (hit rates
of respectively 1.2% and 2.2%). Because of its small size, its
diversity and a high hit rate the Biomol library appears to be
most suited library for the identification of inhibitors of a
particular biological process.
Figure 1. Use of the b-lactamase reporter system to study L. pneumophila effector translocation in macrophages. A. Detection of
translocation of the previously identified Legionella effector LepA. TEM-LepA or TEM-FabI fusions were produced in L. pneumophila and the bacteria
were used to infect J774 cells for one hour at 37uC (MOI=50). Cells were then incubated with the b-lactamase substrate CCF4/AM for two hours at
room temperature. Fluorescence images were captured at 460 and 530 nm up 405 nm excitation and merged. B. Measurement of LepA translocation
in J774 cells as function of multiplicity of infection. C. Measurement of RalF, LepA and LegAU13 translocation in J774 cells (MOI=20) as function of
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Initial screening identified 86 translocation inhibitors which are
associated with diverse biological categories (Figure 3A and Table
S2). We excluded those inhibitors whose documented targets are
not well established or predicted to be irrelevant for translocation.
These included molecules annotated as antifungal, antiviral or
anthelmintic as well as known preservatives (i.e., thimerosal). The
remaining 42 inhibitors were retested under non-HTS conditions
and one compound was found to be a false positive. Other
compounds were found to have been falsely identified as inhibitors
because they interfered with the translocation assay itself
(fluorescence quencher, autofluorescent molecules, inhibitors of
CCF2/AM loading). In order to identify molecules displaying
potential off-target effects we determined the IC50 of the
remaining 25 inhibitors as exemplified in Figure 3. For inhibitors
with documented IC50 we compared the published values to the
determined IC50 for the translocation. This led us to exclude three
inhibitors (DPI, Cantharidin and MBCQ) which displayed IC50
more than one order of magnitude higher than the documented
IC50. The selected 22 remaining molecules were capable of
inhibiting LepA translocation with varying efficiency, ranging
from 63 to 100% inhibition (Table 1). All but one of the molecules
identified in this study are inhibitors of eukaryotic processes,
revealing an unexpected active role for the host cell in the Icm/
Dot effector translocation process. A large class of inhibitors target
proteins of the cytoskeleton (actin and tubulin) as well as proteins
involved in cytoskeleton dynamics (PI3 kinase, N-Wasp). Other
molecules target cell surface proteins such as the PDGF receptor
or the CD45 tyrosine phosphatase which could be viewed as
potential candidate receptors for L. pneumophila internalization.
Somewhat surprisingly, no antibiotics were identified as inhibitors
of translocation in this study. Accordingly, LepA translocation was
not inhibited by antibiotics acting as transcription or translation
inhibitors, suggesting that pre-synthesized effectors are exported
by the Icm/Dot system at early stages of infection.
Even though most inhibitors have a eukaryotic target, one
molecule, FCCP, can also target bacterial cells. FCCP acts as a
protonophore on the bacterial membrane thus collapsing the
proton motive force (PMF).
Protonophores inhibit the Icm/Dot system activity
FCCP and CCCP are structurally related protonophores which
act as proton carriers discharging both the electric potential (Dy)
and concentration (DpH) components of the PMF. CCCP has
been shown to inhibit type III secretion [34] and recent findings
demonstrate that the flagellar type III secretion apparatus
functions as a proton-driven protein exporter [35,36]. CCCP
completely inhibits LepA translocation at concentration as low as
5 mM (Figure 4A). Even when L. pneumophila was pretreated with
10 mM CCCP for 30 minutes, translocation was largely restored
following washout of CCCP (Figure 4A) showing reversibility of
the inhibition. L. pneumophila displays pore forming activity on
macrophages and red blood cells that is mediated by the Icm/Dot
Figure 2. Effect of the three libraries compounds on translocation of the LepA effector. Mean percent inhibition (of two replicates) of
translocation for each compound is plotted (blue circles, Biomol compounds; Orange circles, NINDS compounds; Pink circles, Prestwick compounds),
along with untreated negative control wells (green circles) and positive control wells lacking L. pneumophila cells (red circles). The horizontal bar
indicates 50% inhibition of signal and separates active compounds from inactive compounds and negative controls.
doi:10.1371/journal.ppat.1000501.g002
Host-Dependent Effector Translocation
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assayed by red blood cell lysis. RBC lysis is abolished in a dotA
mutant but, as effector translocation, it is not inhibited by sodium
azide or antibiotics acting as translation inhibitors (Figure 4B).
RBC lysis is detectable as early as 15 minutes after L. pneumophila
contacts the RBC (Figure 4C). In contrast to sodium azide and
antibiotics, CCCP inhibits RBC lysis very efficiently and rapidly.
Since CCCP collapses the proton gradient, it is expected to impact
ATP synthesis by the ATP synthase. CCCP has a moderate
impact on the pre-existing ATP pool, reducing it by about 30%
after CCCP addition (Figure 4D). The energy requirement for
activity of the Icm/Dot system and effector translocation is poorly
understood. Since the IcmO/DotB component of the Icm/Dot
system shows ATPase activity it is expected that Icm/Dot activity
is ATP-dependent. Inhibition by protonophore also suggest that
effector export by the Icm/Dot system is at least partially
dependent on the proton motive force.
Based on these results, other molecules with protonophore or
uncoupling activity are expected to inhibit the Icm/Dot system
and effector translocation. We investigated the identified inhibitors
of LepA translocation for potential direct inhibition of the Icm/
Dot system using the RBC lysis assay (Figure 5A). FCCP showed
strong inhibition of RBC lysis as did the calcium ionophore
Calcymicin and the calcium channel blocker Nifedipine. Phe-
noxybenzamine, PI-110, TPCK, W-7 and Tyrphostin 9 activity
also strongly reduced RBC lysis activity. Consistent with these
findings, the PDGF receptor inhibitor Tyrphostin 9 has docu-
mented uncoupling activity. Interestingly, the NF-kappaB (NF-kB)
inhibitor CAPE has been previously used to show the requirement
of NF-kB for successful L. pneumophila infection and intracellular
replication [38,39]. This initially suggested a role of NF-kBi n
effector translocation during initial interaction with the macro-
phage. However we found that CAPE also directly inhibits Icm/
Dot-mediated RBC lysis (Figure 5A).
Figure 3. A. Categories or targets of inhibitors identified in initial chemical genetic screen. Number of inhibitors in each class is indicated. B. Dose-
response curve of a selected inhibitors on LepA effector translocation. Data from three independent experiments (colored circles) were fitted (colored
line) using the four parameter logistic model to determine the IC50.
doi:10.1371/journal.ppat.1000501.g003
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and inhibits phagocytosis
A large number of inhibitors that had no direct effect on Icm/
Dot activity are molecules targeting the host cytoskeleton (Tubulin
inhibitors, actin inhibitors, PI3K inhibitors). These molecules
are likely to alter phagocytosis, a fundamental function of the
macrophage. We then investigated the effect of all effector
translocation inhibitors on phagocytosis of bacterial particles by
using differential, trypan blue-mediated, quenching of fluorescein-
labeled E. coli [40,41] (Figure 5B). With the exception of FCCP,
Nifedipine and Tyrphostin 9, all the other molecules showed
significant inhibition of bacterial uptake (Figure 5B). Inhibition of
bacterial uptake was expected for the actin polymerization
inhibitors (Latrunculin B, Cytochalasin B) and for the PI3 kinase
inhibitors (LY294002, Wortmannin). To a lesser extent, microtu-
bules also play a role in the phagocytosis process [42] where they
would be required for activity of PI3K at the site of phagocytosis
[43] and may explain the inhibitory activity of Fenbendazole and
Albendazole. In contrast, inhibition of bacterial uptake by other
molecules such as the inhibitors of NF-kB, CD45 and the serine
protease inhibitor or the NO donor Furoxan had not been
previously reported. This may be due to a true involvement of
the inhibitors targets in the phagocytosis process or to some
undocumented off-target effect on phagocytic cells (see discussion).
Regardless of the mechanisms of inhibition, the results show that
inhibitors of Icm/Dot translocation that do not inhibit Icm/Dot
activity itself are enriched in inhibitors of bacterial uptake by the
macrophage. This pinpoints a critical role of phagocytosis in Icm/
Dot-mediated translocation of LepA by L. pneumophila.
Inhibition of non-opsonic phagocytosis prevents effector
translocation
Phagocytosis of L. pneumophila by pulmonary macrophages is
thought to naturally occur via non-opsonic events and under these
conditions L. pneumophila has been found to enter monocytes by
coiling phagocytosis [44]. Interaction of L. pneumophila can be
stimulated by Legionella specific antibodies [45], a situation that
results in conventional FcR-mediated phagocytosis, but that does
not reflect the biologically relevant interaction with host cells. We
tested the effect of L. pneumophila-specific antibody on L. pneumophila
phagocytosis by J774 cells using differential immuno-fluorescence
microscopy [46]. Internalized GFP-expressing L. pneumophila
Table 1. List of identified inhibitors of effector translocation.
Inhibitor Description Category mM % Inhibition IC50 (mM)
Albendazole Inhibitor of tubulin polymerization Cytoskeleton dynamics 50 80 0.9
Cytochalasin B Binds to and inhibits the association and dissociation of
actin filaments
Cytoskeleton dynamics 10 79 1
Fenbendazole Binds to tubulin and blocks polymerization of tubulin into
microtubules
Cytoskeleton dynamics 50 73 0.9
Latrunculin B Inhibits actin polymerization. 10- to 100-fold more potent
than the cytochalasins
Cytoskeleton dynamics 10 86 0.02
LY 294002 A potent and specific inhibitor of phosphatidylinositol 3-kinase Cytoskeleton dynamics 40 87 9.5
Wiskostatin Inhibitor of N-WASP, blocks actin filament assembly and
prevent the activation of Arp2/3
Cytoskeleton dynamics 25 98 9.4
Wortmannin Potent and selective inhibitor of phosphatidylinositol 3-kinase Cytoskeleton dynamics 2 84 0.03
Calcimycin Highly selective calcium ionophore Ionophore or Protonophore 20 81 3.5
FCCP A potent reversible inhibitor of oxidative phosphorylation Ionophore or Protonophore 15 97 2.9
Nifedipine Nifedipine, selectively blocks the voltage-sensitive (L-type)
calcium channel
Ionophore or Protonophore 50 62 39.9
Phenoxybenzamine Irreversibly inhibits calmodulin. Selective a-adrenergic blocker Calmodulin 50 85 15.7
W-7 Binds to calmodulin, inhibiting Ca2+-calmodulin-regulated
enzyme activity
Calmodulin 45 98 17.7
CAPE Inhibits nuclear translocation of NF-kB NF-kappaB 50 92 9.4
Parthenolide Sesquiterpene lactone, inhibits activation of MAP kinase and NF-kB NF-kappaB 30 96 6.5
PI-110 Serine protease inhibitor. Inhibits granzymes A, B, and H2-4 and
cathepsin G5
Serine protease 80 84 25.3
TPCK Inhibitor of chymotrypsin-like serine proteases Serine protease 30 93 4.5
AG-126 Inhibits LPS-induced tyrosine phosphorylation of p42MAPK Kinase or Phosphatase 80 86 34.5
RWJ-60475-(AM)3 Cell-permeable inhibitor of the CD45 tyrosine phosphatase Kinase or Phosphatase 25 89 4.5
Tyrphostin 9 Inhibitor of the PDGFR tyrosine kinase and a potent uncoupler
of oxidative phosphorylation
Kinase or Phosphatase 25 101 3.5
Furoxan A NO donor and potent vasodilator and inhibitor of platelet
aggregation
Others 20 92 3.9
HA14-1 Bcl-2 ligand which antagonizes its function and induces apoptosis Others 10 85 3.9
Mas 7 Activator of G proteins by a mechanism analogous to that of
G protein-coupled receptors
Others 12 79 6.7
Inhibition of translocation for each inhibitor at the indicated concentration is averaged from three independent experiments.
doi:10.1371/journal.ppat.1000501.t001
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accessible to rhodamine-conjugated antibody against Legionella
appear red/orange. Opsonization of L. pneumophila resulted in a
higher number of internalized bacteria (Figure 6A). We also used
differential, trypan blue-mediated, quenching of fluorescein-
labeled L. pneumophila to measure the effect of antibody-
opsonization on L. pneumophila internalization. In four independent
experiments, we found that although the level of phagocytosis by
J774 cells was variable, antibody-opsonization of L. pneumophila
always increased phagocytosis by two- to three-fold in all cases
(Figure 6B). This result is consistent with previous work reporting
that monocyte monolayers infected with L. pneumophila contain
three times as many bacteria in the presence of antibody [47].
To investigate the role of phagocytosis on effector translocation,
we analyzed the effect of inhibitors of actin polymerization and
phosphoinositide 3-kinases (PI3K) under non-opsonized and
artificial, antibody-opsonized conditions. The two inhibitors of
actin polymerization, Cytochalasin B and Latrunculin B dramat-
ically reduce uptake of L. pneumophila by J774 cells, either in the
presence or absence of antibody (Figure 6C). Phagocytosis of L.
pneumophila has been initially reported to be insensitive to PI3K
inhibitors in human monocytes [48]. A similar result was obtained
in Dictyostelium by comparing phagocytosis of L. pneumophila by
wild-type Dictyostelium and a mutant lacking the two known
PI3K [19]. Both strains showed similar levels of phagocytosis of
wild-type strain JR32. The requirement for PI3K for phagocytosis
Figure 4. The protonophore CCCP inhibits Icm/Dot-dependent activities. A. Effect of translation inhibitors (kanamycin, erythromycin) and
protonophore (CCCP) on translocation of the LepA effector in J774 cells. B. Icm/Dot-dependent red blood cell (RBC) lysis by L. pneumophila and effect
of translation inhibitors (kanamycin, erythromycin) and respiratory chain poison sodium azide. C. Time course effect of the CCCP protonophore or the
DMSO carrier on Icm/Dot-dependent RBC lysis by L. pneumophila. D. Effect of the CCCP protonophore on the bacterial ATP levels as a function of
exposure time. In all panels error bars represent standard deviation from three independent experiments.
doi:10.1371/journal.ppat.1000501.g004
Host-Dependent Effector Translocation
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than in Dictyostelium. A recent report shows that phagocytosis of
L. pneumophila by the murine monocyte cell line J774 is mediated
by PI3K and is therefore sensitive to PI3K inhibitors [49].
Consistent with the later study, we found that phagocytosis of L.
pneumophila can be inhibited by PI3K inhibitors LY294002 at
40 mM (not shown) and wortmannin at 2 mM (Figure 6C).
Importantly, all the tested inhibitors inhibited L. pneumophila
phagocytosis even in the presence of antibodies. We then analyzed
the impact of the phagocytosis inhibitors on translocation of LepA
and RalF under non-opsonized or antibody-opsonized conditions
(Figure 6D and 6E). All tested phagocytosis inhibitors have a
dramatic impact on translocation of LepA and RalF under non-
opsonized conditions. The same inhibitors also inhibit transloca-
tion of LepA in the presence of human complement (data not
shown). In contrast, translocation of both LepA and RalF is
resistant to phagocytosis inhibitors under antibody-opsonized
conditions (Figure 6D and 6E). In conclusion, translocation of
Legionella effectors requires phagocytosis under standard, non-
opsonized or complement-opsonized (not shown) conditions.
However, the requirement for phagocytosis can be bypassed by
the presence of anti-Legionella antibody, suggesting that effector
translocation can occur in the absence of phagocytosis by
promoting L. pneumophila binding to macrophages via antibody-
Fc receptors interaction.
The receptor protein tyrosine phosphate phosphatases
CD45 and CD148 are specifically required for efficient L.
pneumophila phagocytosis and effector translocation
As a result of chemical screening we found that the small
molecule RWJ-60475 inhibits L. pneumophila effector translocation.
This suggested that its known target, the receptor protein tyrosine
phosphate phosphatase CD45, is required for L. pneumophila
phagocytosis. To investigate the role of CD45 in L. pneumophila
uptake and effector translocation we used siRNA to knock-down
expression of CD45 in THP-1. Although siRNA treatment was
effective in significantly lowering expression of CD45 to non-
detectable levels, L. pneumophila effector translocation remained
unaffected (Figure S1). However, it has recently been reported that
CD45 and another receptor protein tyrosine phosphate phospha-
tase, CD148 functioned redundantly to regulate B cell and
macrophage immunoreceptor signaling [50]. We used bone-
marrow derived macrophages (BMM) from Ptprj
TM2/TM2, Ptprc
2/
2 mice which do not express CD45 and CD148 to determine if
these tyrosine phosphate phosphatases also functioned redundant-
ly to mediate L. pneumophila binding and uptake. L. pneumophila
bound similarly to wild-type and DKO BMM (Figure 7A)
suggesting that CD45 and CD148 do not constitute receptors
for L. pneumophila binding to macrophages. In contrast, uptake of L.
pneumophila by CD45/CD148-deficient BMM was significantly
reduced (Figure 7B) while the CD45/CD148 double knockout
(DKO) BMM showed unaltered ability to phagocytose E. coli
bacteria (Figure 7B). Translocation of the two effectors RalF and
LepA in the DKO BMM was reduced to the same extent as
uptake (Figure 7C). Antibody opsonization restored effector
translocation in the CD45/CD148-deficient BMMs. These results
reveal the important role of tyrosine phosphate phosphatases for L.
pneumophila entry into macrophages and provide strong genetic
evidence that L. pneumophila phagocytosis is a critical event for
delivery of Icm/Dot effector proteins. It should be noted that
inhibition of bacterial uptake by RWJ-60475 is greater than the
inhibition displayed by the CD45/CD148-deficient BMMs and
suggests that RWJ-60475 acts on the phosphatase activities of
CD148 as well as on other as yet unrecognized tyrosine
phosphatases.
Figure 5. Identified translocation inhibitors inhibit RBC lysis or phagocytosis. A. Effect of the identified translocation inhibitors on Icm/Dot-
dependent RBC lysis by L. pneumophila. B. Effect of the identified translocation inhibitors on uptake of heat-killed E. coli by J774 cells. In both panels
the data are reported as the percentage of untreated sample. Error bars represent standard deviation from three independent experiments.
doi:10.1371/journal.ppat.1000501.g005
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does not require Fc receptor signaling
The fact that phagocytosis is dispensable for translocation when
bacteria contact macrophages through the antibody-FcR interac-
tion suggests that either the tight binding of the bacteria to the cells
or signaling events due to clustering of the high affinity Fc
receptors, are promoting effector translocation. Binding of
antibody-coated particles to FcR induces clustering of the
receptors and initiates a signal transduction cascade leading to
phagocytosis [51,52]. Clustering is then followed by phosphory-
lation of two specific tyrosines on the FcR ITAM domain
(Immunoreceptor Tyrosine-based Activation Motifs) by enzymes
of the Src tyrosine-kinase family [53]. The phosphorylated ITAMs
then recruit Syk kinase which is required for efficient phosphor-
ylation of phosphatidylinositol 3-kinase and is critical for signal
transduction and phagocytosis mediated by FcR [54]. As initial
evidence that FcR signaling is not required for antibody-stimulated
effector translocation, we found that the Syk kinase inhibitor R406
[55] does not inhibit LepA translocation in J774 cells (data not
shown). To further determine if binding of antibody-opsonized
bacteria to the FcR is sufficient to trigger effector translocation, we
used CHO cells expressing the human FccRIIA receptor or a
signaling deficient mutant of FccRIIA, Y2F/Y3F in which the two
tyrosines of the ITAM domain have been substituted by
phenylalanine [56]. Opsonization of Legionella with antibody
strongly stimulated translocation of LepA and RalF in cells
expressing the wild-type or signaling deficient FccRIIA receptors
(Figure 8A). Whereas the wild-type FccRIIA is fully functional and
capable of promoting phagocytosis, the Y2F/Y3F mutant can
bind antibody but does not support phagocytosis [56]. Consis-
tently, translocation of LepA and RalF in CHO cells expressing
either the wild type or the signaling-defective receptors is
insensitive to phagocytosis inhibitors (Figure 8B). We conclude
that the intimate binding of antibody-opsonized L. pneumophila to
Figure 6. Antibody opsonization of L. pneumophila restores effector translocation in the absence of phagocytosis. Effect of antibody-
mediated opsonization of L. pneumophila on uptake of L. pneumophila in J774 macrophages (A and B) and on effector translocation (C). A.
Fluorescence microscopy of GFP-expressing L. pneumophila (JR32) infecting J774 cells in the absence or presence of anti-L. pneumophila antibodies.
Extracellular bacteria were labeled with a rhodamine conjugated antibody. B. Uptake of fluorescein-labeled JR32 by J774 cells in the absence or
presence of anti-L. pneumophila antibodies. Fluorescence signal of extracellular bacteria was quenched with trypan blue. Uptake is reported as the
percentage of fluorescence signal that can not be quenched by trypan blue (i.e. the % of intracellular fluorescence signal). C. Effect of phagocytosis
inhibitors or the DMSO carrier on L. pneumophila uptake by J774 cells in the absence or presence of anti-L. pneumophila antibodies. Uptake is
reported as the percentage of untreated sample. D and E. Effect of phagocytosis inhibitors or the DMSO carrier on TEM-LepA (D) and TEM-RalF (D)
effector translocation in J774 cells in the absence or presence of anti-L. pneumophila antibodies. Translocation is reported as the percentage of
untreated sample. In all panels error bars represent standard deviation from three independent experiments.
doi:10.1371/journal.ppat.1000501.g006
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cytosis to trigger effector translocation.
Phagocytosis-dependent effector translocation is rate
limited
In order to better evaluate the effect of antibody-induced
bacterial contact on effector translocation we adapted the b-
lactamase reporter to study real time translocation of effectors.
The b-lactamase translocation assay has recently been used to
analyze real-time effector translocation by the EPEC type III
secretion system and allowed a more detailed analysis of the
parameters that control effector delivery into host cells [57]. In
contrast to the standard b-lactamase translocation assay where
CCF4 hydrolysis is measured at the end of the infection, the real-
time translocation assay is based on live detection of CCF4
substrate hydrolysis as the TEM-effector fusion is being translo-
cated by the infecting bacterial population. J774 cells were pre-
loaded with the b-lactamase CCF4 substrate in presence of
probenecid which inhibits organic anion transporters [58] and
facilitates loading of CCF4 by inhibiting its active efflux from the
cells. Cells were then infected with L. pneumophila strains expressing
b-lactamase-effector fusion proteins and placed into a plate reader
at 37uC. Hydrolysis of green CCF4 into its blue product by the
translocated TEM-hybrid b-lactamases was then monitored by
measuring blue (460 nm) and green fluorescence (530 nm) every
2 minutes and is reported as the 460/530 ratio. Hydrolysis of
CCF4 was evident after less than 30 minutes in J774 cells infected
with TEM-LepA expressing bacteria at a multiplicity of infection
of 125 or higher (Figure 9A). As expected, decreases of the MOI
led to decreased accumulation rate of the blue CCF4 hydrolysis
product, but was still detectable at a MOI of 15. In contrast, even
at high MOI, no translocation was detectable when J774 cells are
infected by a dotA mutant expressing TEM-LepA. Accumulation of
the CCF4 cleavage product (P) per time unit provides the
hydrolysis rate of CCF4 by the translocated b-lactamase-effector
fusion and an apparent maximum rate (appVmax) can then be
determined. Regardless of the MOI, the appVmax for the LepA
effector is typically reached within 40–50 minutes (Figure 9A). As
more b-lactamase-effector fusion is being translocated, the
appVmax should be proportional to the MOI and we observed a
good correlation of appVmax with MOI up to an MOI of 250
(Figure 9B). We then analyzed the translocation of RalF, LepA
and LegA3 by non-opsonized L. pneumophila at a MOI of 125.
Translocation of RalF and LepA could easily be monitored in real
time (Figure 9C). Translocation of LegA3 was difficult to detect
because the rate of LegA3 translocation is slow and is obscured by
the leakage of the CCF4 substrate from J774 cells even in the
presence of probenecid (Figure 9C). Analysis of the rate of product
formation by the translocated TEM-RalF and TEM-LepA hybrid
proteins shows a burst at respectively 44 and 52 minutes post-
infection (Figure 9D). Under these conditions, phagocytosis is
required for effector translocation and the kinetics of effector
translocation may be limited by the kinetics of the phagocytosis
process. The absence of phagocytosis requirement when contact is
achieved by antibody-FcR interaction may remove this rate-
limiting kinetic step. As expected, we found that opsonization of L.
pneumophila by antibody dramatically increased translocation
efficiency and increased the rate of product formation by more
than 10-fold (Figure 9C and 9D). In addition, the translocation
rates for the TEM-RalF and TEM-LepA hybrid proteins reached
a maximum at respectively 20 and 24 minutes post-infection
which is significantly earlier than in the absence of antibody. In
addition, the hierarchy of the translocation rates of the different
hybrids is maintained in the presence of antibody (RalF.Le-
pA.LegA3). We conclude that antibody-mediated contact of L.
pneumophila with macrophages stimulates translocation by provid-
ing the direct intimate contact normally obtained through the rate-
limiting phagocytosis process.
Figure 7. CD45/CD148-deficient bone marrow-derived macrophages are defective for L. pneumophila phagocytosis. A. Binding of L.
pneumophila to WT and CD45/CD148-deficient bone-marrow derived macrophages (BMM). Errors bars represent standard deviation from six
replicates of two independent experiments. B. Phagocytosis of E. coli and L. pneumophila by WT and CD45/CD148-deficient BMM. Error bars represent
standard deviation from three experiments. C. Translocation of the TEM-LepA and TEM-RalF effectors in WT and CD45/CD148-deficient BMM
(MOI=10). Errors bars represent standard deviation from six replicates of two experiments.
doi:10.1371/journal.ppat.1000501.g007
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Delivery of effector proteins capable of interfering with host cell
processes is a mechanism widely used by bacterial pathogens to
hijack the function of their target cells and cause disease. Effector
delivery is achieved by elaborate effector injection devices such as
the Type III secretion system [23], the Type IV secretion system
[24] and the recently recognized Type VI secretion system [59].
Type III and Type VI secretion of the bacterial effectors respond
to environmental stimuli and can be triggered in vitro by using
various chemicals or media formulations. In contrast, effector
secretion by the L. pneumophila Type IV secretion system has not
yet been detected unless the bacterium encounters a target host
cell [25]. We sought to determine the mechanisms involved in the
signaling of effector translocation by L. pneumophila. Chemical
genetics has recently appeared as a successful strategy to generate
hypotheses regarding underlying biological mechanisms [60,61].
We used a combination of three commercially available annotated
compound libraries of more than 2,500 molecules to understand
the mechanisms involved in triggering effector translocation by L.
pneumophila. We found that a very limited number of molecules can
directly block activity of the Icm/Dot system and that inhibitors of
protein synthesis are not effective at inhibiting Icm/Dot-
dependent effector translocation and pore forming activity
Figure 8. Effector translocation in the presence of antibody does not require immunoreceptor signaling. A. Antibody-stimulated
translocation of the LepA and RalF effector in CHO cells expressing the wild-type or signaling-deficient (Y2F/Y3F) FccRIIA. B. Effect of phagocytosis
inhibitors or the DMSO carrier on antibody-stimulated LepA and RalF translocation in CHO cells expressing the wild-type or signaling-deficient (Y2F/
Y3F) FccRIIA. Error bars represent standard deviation from three independent experiments.
doi:10.1371/journal.ppat.1000501.g008
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novo synthesis of structural or effector proteins. This reinforces the
notion that the Icm/Dot system is in a ‘‘locked and loaded’’ state
before L. pneumophila encounters a target cell. Although Icm/Dot-
dependent effector translocation and pore forming activity are
insensitive to many antibiotics and even to sodium azide, we found
that the same Icm/Dot-dependent processes are strongly but
reversibly inhibited by the protonophore CCCP. The pH gradient
across the bacterial membrane generated by the respiratory chain
is used as an energy source to power the flagellar motor and ion
antiporters. This proton motive force (PMF) has recently been
shown to be required for activity of the Type III secretion system
which functions as a proton-driven protein exporter [35,36]. It is
tempting to speculate that the PMF also powers the Icm/Dot
system. However, inhibitor-mediated collapse of the PMF also
results in a 30% drop of the ATP level which could also explain
the loss of Icm/Dot activity. We can think of at least two ways that
energy may be required for Icm/Dot- dependent RBC lysis.
Energy may be required to assemble a functional TFSS from pre-
existing components. Alternatively, PMF may be required to
translocate pore-forming protein molecules to the RBC membrane
and other target cells. Although PMF would be an immediate and
convenient source of energy to assemble or power the Icm/Dot
system, the interpretation of experiments using inhibitors of the
PMF is challenging and further studies will be required to
ascertain the role of PMF in Icm/Dot effector translocation.
Only a very limited number of molecules were capable of acting
directly on Icm/Dot activities. In contrast, many more molecules
Figure 9. Real time analysis of effector translocation by L. pneumophila. A. Real time detection of CCF4 hydrolysis mediated by TEM-LepA
translocation in J774 cells from L. pneumophila at various multiplicity of infection (MOI). B. Effect of MOI on the apparent maximal rate of product
accumulation mediated by translocated TEM-LepA effector. The blue dotted line represents the ideal correlation between MOI and the apparent
maximal rate of product accumulation (correlation coefficient of 1). C. Effect of antibody opsonization of the translocation efficiency of TEM-RalF,
TEM-LepA and TEM-LegA3. D. Rate of product accumulation mediated by translocated TEM-RalF, TEM-LepA or TEM-LegA3 effectors as function of
time in the presence or absence of antibodies. Legend of panel C applies also to panel D. Rates of product accumulation are expressed as arbitrary
unit per unit of time (min.). The presented data are from a representative experiment.
doi:10.1371/journal.ppat.1000501.g009
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translocation. We found known inhibitors of phagocytosis as well
as inhibitors of other processes. With the exception of the
inhibitors interfering with RBC lysis, all other inhibitors displayed
marked inhibition of phagocytosis of inert bacterial particles in
some cases for apparently unclear reasons. For example, inhibition
of phagocytosis by the two inhibitors of NF-kB, CAPE and
parthenolide was unexpected. Interestingly, another NF-kB
inhibitor has been found to negatively affect phagocytosis by
murine macrophages [62] suggesting a role of NF-kB regulation of
phagocytosis of bacterial particles. In spite of extensive literature
on NF-kB we did not find more direct evidence supporting the
involvement of NF-kB in the phagocytosis process. Similarly,
although RWJ-60475 inhibits bacterial uptake, its known target,
the receptor protein protein tyrosine phosphate phosphatase
CD45 was not previously known to be required for phagocytosis.
In addition, effective siRNA knock-down of CD45 in THP-1 cells
failed to provide evidence for a requirement of CD45 for L.
pneumophila uptake and effector translocation (data not shown).
However, we found that macrophages derived from a mutant
mouse strain lacking both the CD45 and CD148 protein
phosphatases exhibited a defect in L. pneumophila phagocytosis
similar to that reported for ingestion of RBC by the same type of
cells. This suggests that RWJ-60475 may also act on the
phosphatase activity of CD148 or other as yet unrecognized
phosphatases. Large-scale use of specific inhibitors is thus a
powerful tool to generate hypotheses regarding the factors
involved in a given process. However, as illustrated above, the
possible effect of the inhibitors on additional undocumented
targets must be considered.
The strong requirement of phagocytosis for L. pneumophila
effector translocation is remarkable. Other bacterial pathogens
inject bacterial effectors without the requirement of phagocytosis
and some pathogens like Yersinia enterocolitica and enteropathogenic
E. coli even utilize type III-dependent effector translocation to
inhibit phagocytosis [63–65]. We found that when macrophages
are given non-opsonized Legionella, addition of actin depolymer-
izing agents that block phagocytosis severely decreased effector
translocation. However, when the same cells were given antibody
opsonized-Legionella, the actin depolymerizing agents did not
inhibit translocation. We can imagine two different explanations
for these results. One explanation is that in the presence of
antibodies, binding of the bacteria to the macrophages is so
efficient that, as seen by Kirby et al. [37] even in the presence of
actin depolymerizing agents, there is a low level of phagocytosis
that corresponds to the level of uptake observed in the absence of
antibody and inhibitor. An alternative explanation is that the
increased level of Legionella binding to the macrophages in the
presence of antibody permits translocation even when the bacteria
remain outside the cell in the presence of the inhibitors. We favor
the second explanation because we found that opsonized
Legionella were able to translocate effectors to CHO cells
expressing mutant forms of the FccRIIA receptor that are
defective for signaling and cannot promote phagocytosis. Thus,
the signaling cascade induced as a result of antibody-FcR binding
is not required to trigger Icm/Dot-mediated effector translocation.
Under these conditions, it is highly unlikely that the bacteria are
being internalized. This supports the idea that artificially-induced
intimate contact can trigger translocation in absence of phagocy-
tosis and that phagocytosis is not required per se for translocation.
These results provide a resolution for the apparent discrepancy
between published work from our lab done with professional
phagocytes in the absence of opsonization [25] and work from the
Roy lab using CHO(FccRIIA) cells and opsonized Legionella
[66]. Real-time analysis of effector translocation showed that
phagocytosis-dependent translocation is much slower than the
phagocytosis-independent translocation triggered by antibody-
FcR intimate binding. Presumably phagocytosis-dependent trans-
location is slower because the kinetics of phagocytosis adds time to
the kinetics of effector translocation. The absence of evidence for
protrusion of Icm/Dot system suggest that intimate binding may
be needed to overcome the physical barrier established by the
extracellular structures present on the surface of the bacterial or
cellular membranes. Pulmonary macrophage infection by L.
pneumophila generally occurs in the absence of pre-immune
antibodies. Under in vivo conditions it is then likely that L.
pneumophila relies on host cell signaling to stimulate uptake and
achieve intimate contact required for effector translocation. Our
data support a model in which L. pneumophila relies on the
phagocytosis process to generate the intimate contact required for
the translocation of pre-synthesized effector molecules (Figure 10).
The phagocytosis requirement for effector translocation by L.
pneumophila has consequences for its environmental lifestyle.
Indeed, it is believed that amoebae are natural hosts for L.
pneumophila providing a critical environment for its replication and
survival [67]. L. pneumophila may only translocate its effectors when
residing in a phagocytic membrane-bound compartment or once
phagocytosis has been initiated. The translocated effectors can
thereafter alter this compartment so as to create a vacuolar
environment permissive for L. pneumophila replication. In addition,
effector translocation will only be triggered by a potential host cell
energetically competent to perform phagocytosis. Therefore
relying phagocytosis to trigger translocation ensures that it is
occurring only under conditions that could result in a successful
infection, and thus, avoid delivery of effector to a host cell that
cannot support replication. Interestingly, translocation of a Vibrio
cholerae type VI secretion effector also requires internalization by
host cells [68]. This is also somehow reminiscent of activation of
the SPI-2 type III secretion system of Salmonella following
internalization by macrophages [69]. Regardless of the secretion
system used for translocating effector proteins, bacterial pathogens
that interact with phagocytes may have evolved strategies to
ensure that translocation occurs only in the phagosomal/
endosomal microenvironment.
Chemical genetic screening is a successful strategy to identify
host cell functions that are required for effector translocation by L.
pneumophila. Our study was limited to the initial interaction of the
bacteria with host cells but this approach could be applied to the
later stages of infection. The commercial availability of annotated
libraries of specific inhibitors and FDA-approved drugs will
certainly lead to additional studies using chemical genetic
screening. Chemical genetic screening should be considered as a
additional tool to cellular microbiologists and provides an
alternative approach to RNAi-mediated identification of host cell
factors required for a bacterial infection.
Materials and Methods
Cells and materials
J774A.1 and THP-1 cells were obtained from ATCC and
routinely cultivated in RPMI 1640 (Invitrogen) supplemented with
10% fetal bovine serum (FBS). CHO cells expressing the human
FccRIIA or the signaling deficient mutant of Y2F/Y3F [56] were
cultivated in Ham’s F12 nutrient mixture (Invitrogen) containing
10% FCS and 300 mg/mL G418. Phagocytosis inhibitors were
obtained from Biomol (Plymouth Meeting, PA), solubilized in
DMSO and used at the following concentrations : Cytochalasin B
(10 mM), latrunculin B (10 mM), LY294002 (40 mM), wortmannin
Host-Dependent Effector Translocation
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in liquid media ACES [N-(2-acetamido)-2-aminoethanesulfonic
acid]-buffered yeast extract (AYE) or on solid media ACES-
buffered charcoal yeast extract (CYE) plates. Chloramphenicol
and kanamycin were used respectively at 5 mg/mL and 50 mg/
mL. Rabbit polyclonal anti-Legionella antibodies were obtained
by immunizing rabbit with purified major outer membrane
protein (MOMP) [70].
L. pneumophila strains and plasmids
All of the experiment described here were performed with L.
pneumophila Philadelphia-1 derived strain JR32 [71] or with KS79
[16], a constitutively competent comR mutant of JR32. A dotA
deficient strain of KS79 was constructed by transforming KS79
with genomic DNA extracted from the JR32 dotA::Tn903dIIlacZ
strain LELA3118 [71]. Plasmids expressing b-lactamase effector
protein fusions were constructed as previously described [16].
Briefly, PCR product of the effector gene was digested with
appropriate restriction enzymes and cloned in the KpnI-SmaI-
BamHI-XbaI polylinker of pXDC61. Plasmids were transformed
into KS79 or KS79 dotA by natural transformation [72].
Analysis of production of TEM fusion proteins
Bacterial lysates were prepared from L. pneumophila suspension
used for translocation assays (see below). Aliquots were boiled for
5 min. in SDS-PAGE sample buffer and subjected to denaturing
polyacrylamide gel electrophoresis. Proteins from SDS-polyacryl-
amide gels were electrophoretically transferred to nitrocellulose
sheets (Schleicher and Schuell) and subsequently stained with
Ponceau S (Sigma) to check the loading of the lanes. Sheets were
analyzed by Western blotting with monoclonal antibody directed
to the TEM-1 b-lactamase (5 mg/mL, QED Bioscience) as a
primary antibody and an anti-mouse peroxidase conjugate
(20 nG/mL, Pierce) as secondary antibody. Nitrocellulose sheets
were revealed with the SuperSignalH West Dura detection system
(Pierce) and Biomax films (Kodak).
Translocation assay in J774 and CHO FcR-expressing cells
Translocation assay in J774 or CHO FcR cells were performed
as previously described [16]. Briefly, 24H prior to infection J774
cells grown in RPMI 1640 (Invitrogen) containing 10% FCS were
seeded in black clear-bottom 96 well plate at 1610
5 cells/well.
CHO cells were grown in Ham’s F12 nutrient mixture (Invitrogen)
containing 10% FCS and seeded in black clear-bottom 96 well
plate at 5610
4 cells/well. When the infections were performed in
presence of antibodies or inhibitors, J774 or CHO cells were pre-
incubated for 30 min. prior to infection in complete media
containing the anti-Legionella antibodies (1:200 dilution) and/or
inhibitors. L. pneumophila strains carrying the various blaM fusions
were grown on CYE plates containing choramphenicol (5 mg/mL)
and then streaked on CYE plates containing chloramphenicol and
0.5 mM IPTG and grown for 24H to induce expression of the
hydrid proteins. Bacteria were resuspended in RPMI 1640 or F12
nutrient mixture to obtain varying MOI (assuming OD=1 is
about 1.4610
9 cfu/mL) and each well is infected with 10 mLo f
the suspension. After centrifugation (900 g, 10 min.) to initiate
bacterial-cell contact the plate was shifted to 37uC and incubated
for one hour in a CO2 incubator. Cell monolayers were loaded
with CCF4 by adding 20 mlo f6 6 CCF4/AM solution
(LiveBLAzer
TM-FRET B/G Loading Kit, Invitrogen) containing
15 mM Probenecid (Sigma). The cells were incubated for 2 hours
at room temperature, fluorescence was quantified on an Victor
microplate reader (Perkin-Elmer) or Infinite M200 plate reader
(TECAN) with excitation at 405 nm (10-nm band-pass), and
emission was detected via 460-nm (40-nm band-pass, blue
fluorescence) and 530-nm (30-nm band-pass, green fluorescence)
filters. Translocation was expressed as the ratio of fluorescence
emitted at 460 nm and 530 nm (Emission ratio 460/530).
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bioactive molecules libraries and IC50 determination
Screening of the bioactives libraries was conducted at the
National Screening Laboratory for the Regional Centers of
Excellence in Biodefense and Emerging Infectious Disease
(Boston, MA). On the day preceding the infection J774 cells in
were seeded in black clear-bottom 384 well plate (Costar) at 3610
4
cells/well in 25 mL of RPMI 1640 containing 10% FCS. L.
pneumophila carrying the blaM-LepA fusion was grown on CYE
plates containing choramphenicol (5 mg/mL) and then streaked on
CYE plates containing chloramphenicol and 0.5 mM IPTG and
grown for 24H to induce expression of the hybrid protein.
Libraries of bioactives were arrayed in 384-well plates at 5 mG/
mL in DMSO and 0.1 mL of the molecule solution were
transferred per well of the plates containing the J774 cells.
Bacteria were then resuspended in RPMI 1640 to OD=0.21
(3610
8 bacteria/mL) each well is infected with 5 mL of the
suspension. After centrifugation (900 g, 10 min.) to initiate
bacterial-cell contact the plate was shifted to 37uC and incubated
for one hour in a CO2 incubator. Cell monolayers were loaded
with CCF4 by adding 6 mlo f6 6CCF4/AM solution (LiveBLA-
zer
TM-FRET B/G Loading Kit, Invitrogen) containing 15 mM
Probenecid (Sigma). The cells were incubated for 2 hours at room
temperature and fluorescence was quantified on an Victor
microplate reader (Perkin-Elmer). Screening was carried out in
duplicate. IC50 determination were performed similarly using 2.5-
fold serial dilution of the considered molecules in 384 well plates.
The dose-response data were fitted with the GNU General Public
Licensed software QtiPlot using the four parameter logistic model
according to the Assay Guidance Manual Version 5.0 (Eli Lilly and
Company and NIH Chemical Genomics Center).
Red blood cell lysis and measurement of ATP levels
Sheep red blood cell (RBC) were washed in PBS and
resuspended in RPMI at at 5610
7 RBC/mL and 200 mL were
distributed in 96 well plates. Legionella from overnight AYE
cultures were resuspended in RPMI at 1610
9/mL. The RBC
were infected with 50 mL of the bacterial suspension (MOI=5) by
centrifugation at 600 g for 5 minutes and then incubated at 37uC
for up to one hour. Where indicated, CCCP was added to the
bacterial:RBC mixture immediately prior to centrifugation. After
the incubation, the mixtures of bacteria and RBC were
resuspended and then centrifuged again at 600 g for 5 minutes.
The absorbance of hemoglobin in the supernatants was then
measured at 415 nm. Effect of CCCP (5 mM) on bacterial ATP
levels was measured on the same bacterial suspension used in RBC
lysis experiment. Before addition of CCCP a 20 uL aliquot was
removed and added to 2 mL TCA 10%. After a 5 minute
incubation, 20 uL of Tris-Acetate 1 M pH 7.75 were added
followed by the addition of 160 mL ice-cold H2O. The same
procedure was used immediately after addition of CCCP and after
15, 30 and 60 minutes incubation period at 37uC. ATP levels were
quantified using Promega ENLITENH ATP Assay System
Bioluminescence Detection Kit. ATP levels after addition of
CCCP were expressed relatively to the untreated sample.
Phagocytosis assay of E. coli and L. pneumophila by
trypan blue quenching
E coli and L. pneumophila phagocytosis was measured by trypan
blue quenching as previously described [40,41]. Heat-killed E. coli
were fluorescent labeled using fluorescein isothiocyanate (FITC)
[73]. L. pneumophila were fluorescein-labeled with 5,6-Carboxy-
fluorescein succinimidyl ester (FSE) as previously described [22].
In contrast to fluorescein isothiocyanate (FITC) the FSE reagent
does not compromise bacterial viability and allows labeling of live
L. pneumophila [22]. L. pneumophila from 1 mL overnight cultures in
AYE were washed three times in 50 mM potassium phosphate
(pH 8.0) and resuspended in 1 ml 50 mM potassium phosphate
(pH 8.0). FSE was solubilized in DMSO at 10 mG/mL and 10 mL
were added to the bacterial suspension. The bacterium-FSE
mixtures, in 1.6-ml plastic centrifuge tubes, were periodically
inverted throughout a 20-min incubation at room temperature.
The reaction was terminated by resuspending the bacteria in M63
salts and washed three times in M63 salts. Live bacteria were
finally resuspended at 2610
8 cfu/mL in complete RPMI media
and fluorescence of the fluorescein-labeled bacteria (10 mL sample)
was quantified on an Victor microplate reader (Perkin-Elmer) with
excitation at 485 nm (10-nm band-pass filter) and emission at 530-
nm (30-nm band-pass filter). 24H prior to infection J774 cells
grown in RPMI 1640 (Invitrogen) containing 10% FCS were
seeded in black clear-bottom 96 well plate at 1610
5 cells/well.
Before the infection, media was replaced with fresh complete
RPMI 1640 alternatively containing phagocytosis inhibitors and
cells were incubated for 30 minutes. Each well is then infected
with 10 mL of the bacterial suspension (MOI=20). After
centrifugation (600 g, 10 min.) to initiate bacterial-cell contact
the plate was shifted to 37uC and incubated for 30 min. in a CO2
incubator. The media was then removed media and replaced with
50 mL/well of a trypan blue solution (0.25 mg/mL trypan blue,
0.9% NaCl, 13 mM citrate buffer pH 4.4) to quench the
fluorescence of non-internalized bacteria. After a 1 min. incuba-
tion at room temperature fluorescence of the internalized bacteria
was quantified on an Victor microplate reader (Perkin-Elmer) with
excitation at 485 nm (10-nm band-pass filter) and emission at 530-
nm (30-nm band-pass filter). Data were expressed as the
percentage of fluorescence of input bacteria that is resistant to
trypan blue quenching (fluorescence input bacteria/fluorescence
internalized bacteria6100). Alternatively, bacterial internalization
in the presence of inhibitors is expressed as the percentage of
internalization of the untreated sample.
Phagocytosis assay by immunofluorescence microscopy
Phagocytosis assay by immunofluorescence microscopy were
performed as by Hilbi et al. [46]. An IPTG-inducible GFP-
expressing plasmid for L. pneumophila was constructed by cloning a
EcoRI/HindIII-digested PCR product of gfp+ in pMMB207C
giving pXDC31. Gfp-expressing JR32/pXDC31 strain used for
the infections was grown to stationary phase in AYE broth
containing 0.5 mM IPTG to induce Gfp expression. Before
infection, the bacterial cultures were filtered through a 5 mm filter
to remove filamentous bacteria and then diluted in RPMI 1640.
J774 cells on polylysine-coated round coverslips in 24-well plates
were infected with bacteria at an MOI of 20. Alternatively J774
cells were preincubated with polyclonal anti-Legionella antibodies
(dilution 1:200) in complete RPMI 1640 for 30 minutes. The
bacteria were centrifuged onto the phagocytes (700 g, 10 min) to
synchronize infection and incubated for another 30 min at 37uC.
Infected macrophages were washed five times with DPBS and
fixed for 15 min with DPBS containing 3.7% formaldehyde
hydrolyzed from paraformaldehyde. The fixed cells were washed
three times, blocked for 30 min with 5% non-fat milk in DPBS
and incubated for 1 h with a rhodamine-conjugated rabbit anti-L.
pneumophila Philadelphia-1 antibody, diluted 1:100 in blocking
buffer. After washing five times, the coverslips were mounted onto
microscopy slides using the mounting media Vectashield Hardset
(Vector Laboratories). The samples were viewed with a 100X oil
immersion phase-contrast objective on an inverted fluorescence
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siRNA knockdown of CD45 in THP-1 cells
THP-1 cells in exponential growth were electroporated with
siRNA duplexes to human CD45 (ptprc) obtained from Santa-Cruz
biotechnology and Qiagen using Amaxa’s NucleofectorH technol-
ogy. THP-1 cells (1610
6 cells) were resuspended in 100 mLo f
NucleofectorH solution V containing 2 mg of siRNA and
electroporated with program V-01. Fresh media containing
10 ng/mL phorbol 12-myristate 13-acetate (PMA) was added to
the electroporation cuvette and cells were allowed to recover and
differentiate in 96-well (200 mL/well) for 48H. Translocation
assays were then performed as described for J774 cells. CD45
protein levels were analyzed by western-blot using anti-CD45
polyclonal antibody (Santa Cruz Biotechnology).
Differentiation of bone-marrow derived macrophages
(BMM)
BMM were obtained from wild-type and PtprjTM2/TM2
Ptprc2/2 knockout C57BL/6 mice. BMMs were prepared by
culturing mouse BM cells in BMM media (RPMI-1640 with 10%
FCS and 10% culture supernatant from L929 CMG cells
producing M-CSF). Macrophages were used for experiments
between days 5 and 8 of culture. For translocation and uptake
assays, BMMs at day 5 or 6 were plated in 96-well tissue culture
plates (Costar) in BMDM media at 1610
5 per well. BMM were
obtained from two individual mice per genotype.
Binding assays
Binding assays were performed with BMM plated at 1610
6
cells/well in 24-well plates. Cell monolayers were pre-cooled to
4uC and infected with L. pneumophila JR32 at an MOI of 20. After
centrifugation (1000 g, 10 min., 4uC), L. pneumophila was allowed
to interact with macrophages for 30 min. at 4uC to prevent
phagocytosis. Unbound L. pneumophila were removed by five
washes with ice-cold PBS, the cell monolayer was then lysed with
1 mL of distilled water and serial dilutions were spread on CYE
plates for enumeration of bound L. pneumophila.
Real-time translocation assay in J774 cells
24H prior to infection J774 cells grown in RPMI 1640
(Invitrogen) containing 10% FCS were seeded in black clear-
bottom 96 well plate (Corning) at 1610
5 cells/well. The day of the
experiment J774 cells were pre-loaded with CCF4 as follow. Cells
were washed once with CO2-independent media (Gibco Invitro-
gen Corporation, Cat. No. 18045) supplemented with 20 mM L-
glutamine. Media then was replaced with 100 mLo fC O 2-
independent media supplemented with L-glutamine and 10%
FCS (complete CO2IM) plus 20 mL of 6X CCF4/AM solution
(6 mM CCF4/AM, 20 mM probenecid in 5% v/v solution B and
67% v/v solution C prepared as described by the manufacturer,
LiveBLAzer
TM-FRET B/G Loading Kit - Invitrogen) and cells
were incubated 40 min. at 28uC. Solution B and C are from
LiveBLAzer
TM-FRET B/G Loading Kit and are respectively
100 mg/mL PluronicH-F127, 0.1% acetic acid in DMSO and
24% w/w PEG 400, 18% TR40 in volume in water. Cells were
then washed once with wash media (2 mM CCF4/AM - without
solution B and C, 4 mM probenecid, 20 mM L-glutamine in
CO2-independent media) and wash media was replaced with
120 mL of complete CO2IM containing 2 mM CCF4/AM, 15%
v/v solution C and 4 mM probenecid. Bacteria from CYE plates
(5 mg/mL chloramphenicol and 0.5 mM IPTG) were resuspended
in CO2IM to obtain various MOI (assuming OD=1 is about
1.4610
9 cfu/mL) and each well is infected with 10 mL of the
suspension. After centrifugation (900 g, 10 min.) to initiate
bacterial-cell contact the plate was plated into a plate reader
(Infinite M200, Tecan) preset at 37uC and the infections took
place in the plate reader. Cells were excited at 405 nm and
fluorescence of substrate (CCF4) and product (released coumarin
moiety of CCF4) was recorded respectively at 530 nm and
460 nm at 120 seconds intervals. Assays were carried out in
triplicate wells and data were collected with Magellan software
v6.4 (Tecan) and then automatically processed in Excel (Micro-
soft) essentially as described by Mills et al. [57] : Data from
triplicate wells were averaged and fluorescence values of blank
(well without cells) were subtracted from fluorescence values
recorded at 460 nm and 530 nm. The 460/530 nm ratio was
calculated and smoothed with a moving average in a 5 points
window. The product concentration ([P], arbitrary units) were
calculated as previously described [57] : [P]=(Praw2Pblk)/
(S02Sblk) where Praw is the product fluorescence measured at
460 nm; Pblk, background fluorescence at 460 nm; S0, measured
substrate fluorescence at 530 nm at T=0; Sblk, background
fluorescence at 530 nm. S0 normalizes the well-to-well variation in
number of J774 cells. The rate of product formation, AppV,
values were extracted from the data by subtracting each [P](t) with
its predecessor, [P](t-1), divided by 120 seconds, which is the time
interval between each two measurements. AppVmax is the highest
rate of product formation reached during the translocation
process.
Supporting Information
Figure S1 Effect of CD45 knock-down by siRNA on effector
translocation in THP-1 cells. A. Western-blot analysis of CD45
expression level in THP-1 cells after siRNA treatment. B.
Translocation of the LepA effector in siRNA-treated THP-1 cells.
Found at: doi:10.1371/journal.ppat.1000501.s001 (0.29 MB TIF)
Table S1 Complete list of all tested bioactive molecules (Biomol,
NINDS and Prestwick collections).
Found at: doi:10.1371/journal.ppat.1000501.s002 (0.31 MB XLS)
Table S2 List of the 86 molecules from the initial screening
which showed more than 50% of inhibition.
Found at: doi:10.1371/journal.ppat.1000501.s003 (0.04 MB XLS)
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